Association of Body Composition with Outcome of Docetaxel Chemotherapy in Metastatic Prostate Cancer: A Retrospective Review

• Weixin Wu,

  Affiliation Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Xiandong Liu,

  Affiliation Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Patrick Chaftari,

  Affiliation Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Maria Teresa Cruz Carreras,

  Affiliation Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Carmen Gonzalez,

  Affiliation Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Jayne Viets-Upchurch,

  Affiliation Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Kelly Merriman,

  Affiliation Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Shi-Ming Tu,

  Affiliation Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Shalini Dalal,

  Affiliation Department of Symptoms Control and Supportive Care, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Sai-Ching J. Yeung

  * E-mail: syeung@mdanderson.org

  Affiliations Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯